Bright Biotech
Bright Biotech produces high-quality recombinant proteins and growth factors by expressing them in plant chloroplasts. The company utilizes this molecular farming technology to provide scalable and sustainable solutions for the cell culture and regenerative medicine industries. Their production method focuses on safety and ultra-scalability for therapeutic and research applications.
Visit websiteManchester, UK
Biotechnology
Life Sciences
Regenerative Medicine
Foodtech
Funding summary
- Total raised
- €3.1M
- Funding rounds
- 1
Investors in Bright Biotech
Investors on record for Bright Biotech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Bright Biotech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors